BioPAN: a web-based tool to explore mammalian lipidome metabolic pathways on LIPID MAPS. by Gaud, Caroline et al.
SOFTWARE TOOL ARTICLE
   BioPAN: a web-based tool to explore mammalian 
lipidome metabolic pathways on LIPID MAPS [version 2; peer 
review: 3 approved]
Caroline Gaud 1, Bebiana C. Sousa 2, An Nguyen1, Maria Fedorova3, 
Zhixu Ni 3, Valerie B. O’Donnell4, Michael J.O. Wakelam2+, Simon Andrews 1, 
Andrea F. Lopez-Clavijo 2
1Bioinformatics Group, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK 
2Lipidomics facility, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK 
3Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, Center for Biotechnology and Biomedicine, Universität 
Leipzig, Leipzig, 04109, Germany 
4Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK 
+ Deceased author
First published: 06 Jan 2021, 10:4  
https://doi.org/10.12688/f1000research.28022.1





Lipidomics increasingly describes the quantification using mass 
spectrometry of all lipids present in a biological sample.  As the power 
of lipidomics protocols increase, thousands of lipid molecular species 
from multiple categories can now be profiled in a single experiment. 
 Observed changes due to biological differences often encompass 
large numbers of structurally-related lipids, with these being 
regulated by enzymes from well-known metabolic pathways.  As 
lipidomics datasets increase in complexity, the interpretation of their 
results becomes more challenging.  BioPAN addresses this by 
enabling the researcher to visualise quantitative lipidomics data in the 
context of known biosynthetic pathways.  BioPAN provides a list of 
genes, which could be involved in the activation or suppression of 
enzymes catalysing lipid metabolism in mammalian tissues.
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Introduction
Lipids (fats) are essential and diverse families of molecules 
that play structural, energy storage and signalling roles. They 
are connected through complex metabolic pathways, which 
comprise linked series of enzymatic reactions (several are 
outside cells, e.g. PLA2 isoforms, autotaxin). Thus, lipids can 
be substrates, products or intermediates. It has been estimated 
that there are approximately 3–5000 different lipid species in 
mammalian cells although the true number is still unknown and 
extremely difficult to reliably measure1,2. In recent years, great 
advances have been made in our ability to experimentally deter-
mine the elemental composition and quantitation of lipid levels 
in biological samples, with the advent of rapid scanning benchtop 
mass spectrometers (MS), in particular high-resolution configu-
rations such as Orbitrap, and ToF. Liquid chromatography-MS, 
either tandem or high resolving power, interfaced with process-
ing pipelines such as Lipid Data Analyser (LDA), Lipid-
Finder, LipidHunter, MS-Dial, XCMS and many others makes 
it feasible to simultaneously monitor the dynamic changes in 
hundreds of lipid molecular species in biological samples3–7.
As the quantity and detail of quantitative lipid data continues 
to grow it has become considerably more challenging to inter-
pret the complex sets of changes within the lipidome8. Relevant 
biological perturbations usually happen not at the level of a sin-
gle lipid molecular species in isolation, but as broad sets of 
changes over entire lipid classes and subclasses9. For example, 
a group of phosphatidylcholines will tend to change together in 
the same direction, since they are being regulated by the same 
enzyme isoform(s). This introduces characteristic patterns in the 
data that can reveal important clues as to the underlying level of 
genetic and transcriptomic regulation. Consequently, there is a 
need for software tools to automate and facilitate biosynthetic 
pathway scale analyses with lipids grouped according to structural 
motifs. Nguyen et al. and Hann et al. described the analysis of 
quantitative lipidomics datasets at pathway levels10–12. Here, we 
have integrated the biosynthetic metabolic levels into BioPAN. 
So, BioPAN combines current knowledge of lipid metabolism 
with a statistical analysis functionality, by comparing two bio-
logical conditions to identify activated or suppressed pathways, 
and presents the results in an interactive graphical display. BioPAN 
works with data resolved to the level of individual lipid molecu-
lar species, but it can also aggregate results at the subclass level 
to simplify the interpretation. Mammalian reaction information 
is converted into a metabolic pathway within BioPAN, allow-
ing it to predict the most likely lipid transforming genes modu-
lated by an experiment, to provide direct biological insight and 
generate hypotheses that can be experimentally tested.
BioPAN is openly available on the LIPID MAPS® Lipidomics 
Gateway, at https://lipidmaps.org/biopan/. The tool is designed 
to allow users to upload and analyse their own data, and exam-
ple datasets are also provided for evaluation. BioPAN is fully 
integrated with LipidLynxX, allowing users to convert differ-
ent naming (short notation) conventions from diverse software 
inputs to be able to make it readable on BioPAN. Addition-
ally, LipidLynxX will convert lipid results with fatty acid posi-
tion, double bond location, and stereochemistry into a sum 
composition of carbon number and double bond equivalents. 
For example, DAG (16:0/20:1(Z11)), is converted by Lipid-
LynxX to DG 36:1. BioPAN offers a link with LIPID MAPS 
Structure Database (LMSD)9. So, BioPAN aids for automatic 
integration of lipid metabolism with lipid profiles, finding 
strong relationships between lipid substrates and lipid products 
catalysed by active or suppressed enzymes.
Methods
Implementation
The statistical model used in BioPAN was originally described 
by Nguyen et al.10. In brief, BioPAN uses data from replicated 
quantitative lipidomics experiments with two biological experi-
ments: a condition of interest (treated) and a control condition. 
BioPAN calculates statistical scores for all possible lipid path-
ways to predict which are active or suppressed in the treated 
samples compared to the control set.
The BioPAN workflow relies on the calculation of the Z-score, 
which considers the mean and the standard deviation of the 
experiment assuming a normally distributed data of lipid sub-
classes. A probability function (P) is computed and subtract-
ing from one to obtain Q, which in turn is the probability that a 
Z-score is due to chance. The Z-score is then used to predict 
whether a particular reaction is significantly (p < 0.05) chang-
ing between control and treated conditions. Z-scores for all 
reactions in a pathway are combined using a cumulative func-
tion (CDF) to give a global pathway Z-score. The set of equa-
tions used to calculate Z-scores are presented and discussed 
elsewhere10. Changing reactions are classified as activated or 
suppressed depending upon the direction of change. BioPAN, 
by default, calls a reaction or pathway as significantly modified 
at a level of p < 0.05 (corresponding to Z > 1.645).
Operation
BioPAN is implemented as an open access web-based tool. 
The front end uses HTML, jQuery (v3.5.1) for the interface and 
           Amendments from Version 1
•      In the introduction to summarise the overall objective of the 
application note.
•      In the methods to show the corresponding Z-score to 
p<0.05.
•      In the conclusions about further developments to the 
database.
•      In the pathway calculation section to choose the level of 
significance in the calculation.
•      In the pathway options to include logical operators
•      In the Operation section to describe “unprocessed” species. 
•      In the export option to include other graphics formats
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the Cytoscape.js library (v3.10.2)13 to draw and manipulate the 
results graphs. The server-side code uses PHP (v7.4.11) for 
request handling and R (v4.0.2) for data processing and 
statistical analysis. BioPAN runs on all modern web browsers 
and is available at https://lipidmaps.org/biopan/.
BioPAN allows uploading of lipidomics datasets containing 
quantitative data from two different experiments or conditions 
(e.g. wild type against treated/knock-out). The use of BioPAN 
is simple and intuitive with a user-friendly interface. The data 
files should have a minimum of two replicates per condition, as 
BioPAN compares the changes between the experiments. Bio-
PAN takes an input file in .csv (Comma-Separated Values). The 
first column of the file should include the lipid abbreviation 
subclass followed by the notation e.g. PC 38:4, PC 18:0_20:4, 
PC 18:0/20:4, or PC 18:0/20:4(5Z,8Z,11Z,14Z), for glyceropho-
pholipids, glycerolipids, and sterol lipids. Sphingolipid molecu-
lar species written as e.g. d18:1/20:4, or 18:1;O2/20:4, where 
18:1;O2 is the sphingosine base and 20:4 is the N-acyl chain 
liked to the sphingosine base are also recognised in BioPAN. 
Non-conventional nomenclature like DG(aa-34:0, DG(ea-34:1) 
is not recognised by BioPAN and the user manually need to 
change the lipid subclass abbreviation14. There are additional 
instructions about the structure of the data file following the 
link https://lipidmaps.org/biopan/doc/step1.html, which directs 
the user to each lipid subclass abbreviation in LIPID MAPS® 
Lipidomics Gateway.
The first step in BioPAN is to load a file of quantitative lipid-
omics data. After uploading, BioPAN uses the LipidLynxX15 
tool to cross-match some lipid names into the LIPID MAPS® 
Lipidomics Gateway nomenclature style according to the guide-
lines from COMP_DB (https://www.lipidmaps.org/resources/
tools/bulk_structure_searches_documentation.php)9,14,16. BioPAN 
then classifies the submitted lipids molecular species  as 
either unrecognised, processed, or unprocessed. Unrecognised 
molecular species are lipids whose subclasses are not included 
into BioPAN database, while unprocessed species are part 
of BioPAN, but were not associated with any reactions. The 
unprocessed category corresponds to lipid molecular species 
that did not have a matching molecular species, as a reactant and 
product, with the same number of carbons and double bonds. 
For example, a substrate molecular species, such as PA 34:2 
should have a matching product with the same sum composition 
(e.g. DG 34:2).  Additionally, some biological reactions require 
fatty acid or fatty-acyl-CoA molecular species. So, a lack of 
these subclasses in the input file prevents BioPAN to build up 
the reaction between substrates and products. If the substrate or 
product is not part of other reaction within the pathway, BioPAN 
will report it as unprocessed, such is the case of triacylglycer-
ides (TG) subclasses. On other instances, like phosphatidylcho-
line (PC) and lysophosphatidylcholine (LPC), where PC is the 
substrate in the reaction to produce phosphatidic acid (PA) and 
LPC is the substrate to produce lysophosphatidic acid (LPA), 
those lipid subclasses molecular species can be considered as 
processed by BioPAN. BioPAN’s database was manually col-
lated followed by a validation using available literature. The 
database currently contains 94 lipid reactions identified in 
mammals, covering 41 lipid subclasses. Only processed molecu-
lar species, e.g. those which can be associated with at least one 
reaction, are used for downstream analysis.
The second step within BioPAN requires users to associate each 
sample with a condition. (e.g. sample names: control1, treated1, 
or control2, treated2, and so on, with their respective replicates). 
Each condition requires a minimum of two replicas (three or 
more replicas per condition are strongly recommended). Once 
assignments have been made, BioPAN searches for reactions 
and pathway changes between these. Following analysis com-
pletion, the user is directed to the results page (Figure 1). The 
main viewport shows an interactive graph comprising lipids 
and reactions assigned to the lipids included in the input file 
uploaded. The user can select how the pathways are displayed 
in the interactive graph by manually moving the nodes in the 
graph, while the link between product and substrate is main-
tained. Thus, providing a view of all possible reaction pathways. 
The side panel provides a legend for the graph and controls to 
modify the specifics of the analysis performed and the level 
of detail in the graph. The legend describes the shape of the 
nodes, which denote the lipid subclass, and the colour of the 
nodes represent the pathway status (active/suppressed or none). 
Each arrow between two nodes (lipid subclass/lipid molecu-
lar species) depicts the reaction direction between the two 
lipids. The colour of the arrows depends on the value of the 
Z-score (see the Implementation section), where green indicates 
a positive Z-score and purple negative, as shown in Figure 1. 
The user can click on the arrows connecting each node and a 
pop table is generated by BioPAN showing all the lipid molecu-
lar species selected and non-selected in the reaction between 
two nodes (see Extended Data, Table S-1). Selecting the arrow 
is only functional when selecting the lipid subclass level in the 
pathway options (described in the section below). Addition-
ally, information on lipid subclasses and molecular species 
are available by clicking on the nodes, linking to the LMSD 
database (https://www.lipidmaps.org/data/structure/index.php).
The bottom panel shows a tabular view of statistically significant 
(p < 0.05 equivalent to Z-score > 1.645) results.
Display options. The pathway options on the left of the screen 
allow users to customize the display of results in the graph. 
BioPAN arbitrarily chooses two conditions to compare (condi-
tion of interest and control condition, see Figure 1. The user 
can change conditions to compare using the drop-down menu 
(Figure 1). Users can choose to view pathways based on either 
the lipid subclass or on the fatty acyl composition. They can also 
choose which pathways to highlight in the main graph. Users 
can opt for either significantly active (condition of interest > 
control) or significantly suppressed (condition of interest < con-
trol) pathways. Where the same reaction can participate in multi-
ple pathways, users can also choose to view only the most active 
(or most suppressed) pathway. This will highlight only the path-
way with the highest individual pathway level Z-score for path-
ways containing reactions where a substrate is the starting agent 
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in a reaction. In other words, selecting most active or most 
suppressed status still follow the rule for the active/suppressed 
status in terms of colours and Z-scores as discussed above. 
However, the Z-scores in an active/suppressed single reaction 
(e.g. PC→DG) are compared for substrates, intermediates, and 
products following each step of the pathway. For example, in 
the cerebral cortex (with pathway options: active status, sub-
class level, reaction subset of lipid data, 0.05 p value, no paired-
data), reactions within multiple pathways like PC→DG→MG 
and PC→DG→PA. PC is the initial substrate and have indi-
vidual reaction Z-scores of 3.083 (PC→DG), 2.054 (DG→MG), 
and -0.408 (DG→PA). It can be observed above that PC→DG 
is common for the first step in both pathways, and then BioPAN 
selects the most active reaction with the highest Z-score for 
the second part of the pathway. So, the Z-score of DG→MG 
is greater than the score for DG→PA. Thus, PC→DG→MG 
is most active pathway compared to PC→DG→PA. There 
might be more than one active pathway with one lipid-initiated 
substrate (e.g. DG→TG, DG→PE→PS, and DG→PC→CL), 
the same principle is applied, and BioPAN will consider only 
one of those pathways as most active.
Users can also choose to have the nodes in the graph aggregated 
into lipid subclasses, or they can view individual lipid molecu-
lar species. by using the level drop down menu. Alternatively, 
the user can opt to view only reaction chains using the subset of 
lipid data menu, which contains pathways stored within BioPAN 
(e.g. Biosynthesis of Sphingomyelin or de novo lipogenesis). 
Changing any parameter within the pathway options affects 
both the graph and the results tables.
An all lipid displayed view can be filtered to display only a 
user-selected subset of lipids. These can be chosen either from 
a text box, or using a tree of checkboxes for each subclass, 
Figure 1. Main results page view for BioPAN. Pathways are displayed as an interactive graph at the centre of the screen. Users have 
control over the information presented in the graph using the menus on the left side panel and results tables are displayed at the bottom 
of the screen.
Page 5 of 18
F1000Research 2021, 10:4 Last updated: 09 JUN 2021
allowing users to focus on particular lipids of interest (see 
Extended Data, section S-2, Figure S-1). The search box allows 
the user to search for one or two queries using the logical opera-
tors AND / OR. Selecting the AND operator, the user can view 
lipid subclasses or molecular species for which the name 
implies both queries. For example, searching for “PC” and 
“34:0” on the lipid molecular species graph displays lipids 
“PC(34:0)” and “O-PC(34:0)”. Choosing the OR operator 
allow the user to visualise lipids whose names includes one 
of the two searches. For instance, searching “LPC” or “LPA” on 
the subclasses graph displays lipids “LPC”, “O-LPC” and “LPA”.
Calculation options. Under the Pathway Calculation sec-
tion, the user can control details of the statistical calcula-
tion. They can change the threshold for significance from the 
default of p < 0.05. If replicates in the uploaded data were 
generated as matched pairs (e.g. control and treated sample com-
ing from the same animal) then the calculation can also take 
this into account in the t-test step of the analysis.
Exporting results. Results of the statistical analysis of 
active/suppressed pathways are presented in four tables at the 
bottom of the page, where predicted gene changes can be visu-
alised. Export options are also available on the top right corner 
in the BioPAN viewport, where the main graph can be exported 
in several formats (JPEG / PNG / JSON / TXT) and tables 
are exported as TSV files.
Example use case
Lipidomics data from cerebral cortex and liver of young and 
aged mice17 were used here as an example to illustrate how to 
use BioPAN and interpret its results. Ando et al.17 compared 
the lipid profile of different tissues in young and aged mice with 
the aim of detecting age-related as well as tissue-specific lipid 
modifications. The authors clustered alkylacyldiacylglycerols 
and deoxysphingolipids molecular species, reporting accumu-
lation of deoxysphingolipids and ether-linked diacylglycerols 
in both tissues. Additional lipid subclasses were measured from 
Ando et al. (Additional information file 3), but those results 
were not discussed in the original publication10. The results from 
Ando et al. are used here to show how BioPAN can provide a 
wider analysis of the lipid level changes and the relationship 
between different lipid subclasses.
The datasets from the original paper, were downloaded as 
TXT files from Metabolomics Workbench (Project ID PR000713, 
Studies ID ST001065 and ST001066) and are available as 
underlying data (see data availability section). Each file was 
imported as described in the method implementation section. 
Pathway options and pathway calculations settings were as 
follows: Type: Lipid; Status: Active; Level: Lipid subclass; 
Subset of lipid data: Reactions; Condition of interest: Aged; 
Control condition: Young; p value: 0.05; Paired data: No.
The lipid network at the lipid subclass level is shown in 
Figure 2A for the liver and Figure 2B for the cerebral cortex. 
The lipid pathway graph allows the user to quickly spot trends 
and differences between the two sets of samples. Figure 2 shows 
that reactions using ether-linked diacylglycerol (O-DG) as a 
substrate are suppressed in both liver and cerebral cortex in 
old versus young, which agrees with the reported accumula-
tion of this particular lipid subclass by Ando et al.17. Here, 
BioPAN also found tissue-specific differences in lipid metabo-
lism. For example, the reaction pathway results of aged mouse 
liver suggest active metabolism leading to accumulation of 
triacylglycerols (TG, Z-score = 2.301), a form of energy stor-
age, contrary to a catabolic metabolism of TG observed in the 
cerebral cortex (Z-score = -2.612).
BioPAN also shows more differences in the metabolism of sphin-
golipids between the tissues. Specifically, in the liver the path-
way is shifted towards the formation of ceramide-1-phosphate 
(Cer1P), while in the cerebral cortex sphingolipid metabolism 
points towards the formation of sphingomyelin (SM). Moreover, 
in the liver, glycerophospholipids and lysophospholipids 
synthesis is active with exception of LPA, contrary to what it is 
observed in the cerebral cortex, where glycerophospholipids 
and lysophospholipids pathways are suppressed, but production 
of LPA is favoured.
BioPAN provides tables showing the suggested genes known 
to be involved in each reaction. Table 1 shows the lipid sub-
class active reaction results generated for the liver dataset. 
For example, the pathway PE→PC→PS→LPS designates the 
genes PEMT, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F. It 
should be noted that the default nomenclature of the genes in 
BioPAN corresponds to human species. In the example case 
presented here, the lipidomics data was obtained from mice, 
and although most often human and mouse genes are the 
same, there can be subtle differences between species. Thus, 
the user is encouraged to assign the gene according to the spe-
cies in their own study. To aid the user in identifying the species 
each gene in Table 1 has a link that exists in the LIPID MAPS® 
Proteome Database (LMPD) (https://lipidmaps.org/resources/
databases/index.php?tab=lmpd). For example, in Table 1 PEMT 
gene refers to a table containing the name and species of the 
gene, including a unique LMP ID for each gene/species pair. 
Thus, LMP002477 is assigned to the gene Pemt for mouse, 
which converts PE to PC. The status of this pathway might be 
changed by the loss of function or altered activity in any of the 
enzymes involved. Therefore, the list provided by BioPAN might 
help guide integration of lipidomics with proteomics or tran-
scriptomics data as it directly suggests target proteins for 
further analysis.
Looking at fatty acids (FA) pathways at the molecular species 
level with BioPAN (Figure 3) shows the FA network obtained 
for liver and cerebral cortex of aged in comparison to young 
mice. The results show active metabolism towards the produc-
tion of monounsaturated FA 16:1 and polyunsaturated FA 20:4, 
FA 20:5, and FA 22:4 in the cerebral cortex compared to the 
liver. Additionally, BioPAN has highlighted accumulation of 
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the long acyl chain, polyunsaturated FA 24:5 in liver, which 
is associated with the activation of the ELOVL2 gene found in 
Table 2. Moreover, the results shown in Table 2 suggest a 
general activation of elongases (ELOVL) rather than desatu-
rases (SCD) which was found to be a common trait in both 
tissues.
Figure 2. BioPAN lipid networks. Lipid network graphs exported from BioPAN for the liver (A) and the cerebral cortex (B) of aged mice 
compared to young mice17. Green nodes correspond to active lipids and green shaded arrows to active pathways. Reactions with a positive Z 
score have green arrows while negative Z scores are coloured purple. Pathways options: aged condition of interest, young control condition, 
lipid type, active status, subclass level, reaction subset of lipid data, p value 0.05, and no paired-data.
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Conclusion
Modern lipidomics techniques generate a huge amount of data 
and information on many lipid subclasses, making the interpre-
tation of results challenging. BioPAN provides several advan-
tages over simpler analyses of individual lipids. Mapping of 
the lipid network graph provides a bigger picture allowing a 
new perspective on the data where new connections can be 
made, and a study can be moved forward into particular areas of 
interest. BioPAN offers a quick visualisation of differences in 
lipid pathways in mammalian studies and suggests genes and their 
enzyme products involved in those differences. Further work 
into the BioPAN database will be carried out to incorporate 
new biosynthetic pathways, such as: cholesterol, eicosanoids, and 
oxidised lipid subclasses, among others. Addition of glucosyl and 
galactosyl ceramides (Glc/Gal-Cer) to complement to the existing 
sphingolipids pathway in BioPAN will also be considered.
Table 1. BioPAN predicted genes of the lipid active reactions in liver of aged vs young mice. Table contains the active 
reactions chains found by BioPAN according to the Z-score values. Several genes are predicted as being involved in the current 
status of each reaction based on their function. Pathway options: aged condition of interest, young control condition, lipid type, 
active status, subclass level, reaction subset of lipid data, p value 0.05, no paired-data.
lipid subclass active reaction (Aged vs Young)
Reaction chains Z-score Predicted genes
PE→PC→PS→LPS 3.978 PEMT, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
DG→PC→PS→LPS 3.686 CHPT1, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
PE→PC→LPC 3.519 PEMT, PLA2G2E, PLA2G2A, PLA2G2D, PLA2G2F, PLA2G1B 
LPA→PA→PG→LPG 3.367 AGPAT1, AGPAT2, AGPAT3, AGPAT4, AGPAT5, CDS1, CDS2, PTPMT1, PLA2G4D, PLA2G4F, 
CRLS1 
PE→PC→PA→PG→LPG 3.179 PEMT, PLD1, PLD2, CDS1, CDS2, PTPMT1, PLA2G4D, PLA2G4F, CRLS1 
DG→PC→LPC 3.161 CHPT1, PLA2G2E, PLA2G2A, PLA2G2D, PLA2G2F, PLA2G1B 
PG→LPG 3.077 PLA2G4D, PLA2G4F, CRLS1 
LPA→PA→PS→LPS 2.898 AGPAT1, AGPAT2, AGPAT3, AGPAT4, AGPAT5, CDS1, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
DG→PE→LPE 2.815 CEPT1, PLA2G4C 
PE→PS 2.700 PTDSS2 
PC→PS→LPS 2.657 PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
DG→MG 2.507 PNPLA2, PNPLA3 
DG→TG 2.301 DGAT2 
DG→PC→PA 2.280 CHPT1, PLD1, PLD2 
dhSM→dhCer→Cer→Cer1P 2.218 SGMS1, SGMS2, DEGS1, DEGS2, CERK 
DG→PA 2.050 DGKA, DGKB, DGKD, DGKE, DGKG, DGKH, DGKI, DGKK, DGKQ, DGKZ 
O-PE→O-LPE 1.942 PLA2G4A 
LPA→PA→PI 1.878 AGPAT1, AGPAT2, AGPAT3, AGPAT4, AGPAT5, CDS1, CDS2, CDIPT 
PC→LPC 1.843 PLA2G2E, PLA2G2A, PLA2G2D, PLA2G2F, PLA2G1B 
PE→PC→PA→PI 1.837 PEMT, PLD1, PLD2, CDS1, CDS2, CDIPT 
PS→LPS 1.668 PLA2G2E, PLA2G2A, PLA2G2F 
PE→PC→CL 1.667 PEMT, TAZ 
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Figure 3. BioPAN fatty acids networks. FA graphs exported from BioPAN tool for the liver (A) and the cerebral cortex (B) of aged mice 
compared to young mice17. Green nodes correspond to active lipids and green shaded arrows to active pathways. Reactions with a positive 
Z score have green arrows while negative Z scores are coloured purple. Pathways options: aged condition of interest, young control 
condition, lipid type, active status, subclass level, reaction subset of lipid data, p value 0.05, and no paired-data.
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Open Science Framework: BioPAN: a web-based tool to explore 
mammalian lipidome metabolic pathways on LIPID MAPS, 
https://doi.org/10.17605/OSF.IO/PKD6B18.
This project contains the modified dataset from Ando et al.17 
according to BioPAN’s requirements:
•    Cerebral cortex dataset: https://osf.io/reavk/
•    Liver dataset: https://osf.io/zd4as/
Extended data
Open Science Framework: BioPAN: a web-based tool to explore 
mammalian lipidome metabolic pathways on LIPID MAPS, 
https://doi.org/10.17605/OSF.IO/PKD6B18.
This project contains the following extended data:
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Software availability
Software, documentation and tutorial video are available 
from: https://lipidmaps.org/biopan/.
Archived source code at the time of the publication: https://doi.
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License: GNU GPL 3.0
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calculation” section, would it be possible to let the user input any value for the significance 
threshold, rather than choosing from a few drop-down options? 
 
1. 
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could filter for “PC 32:1 AND PE 32:1”, or “38:5 OR 38:6”. 
 
2. 
Ultimately, the tool relies on information contained in the pathway database. While using an 
in-house dataset for testing the tool, a large number of species were unfortunately 
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3. 
Page 9, Acknowledgements: change “In memorium” to “In memoriam”.4. 
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Suggestions:
With regards to the statistical model used by the software. Could the authors elaborate on 
whether correction for multiple testing is done for p-value calculations?
○
--> BioPAN does not correct for multiple testing as it calculates a Z-score to find stronger 
relationships within the data, hence higher Z-scores represent a more interesting result 
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than others.
In the “Pathway calculation” section, would it be possible to let the user input any value for 
the significance threshold, rather than choosing from a few drop-down options?
○
--> The drop-down menu has been replaced to a text box and it has been incorporated into 
BioPAN. 
The “Filter” field in the “Pathway options” section is very useful; however, it seems to take 
only one value at a time. Would it be possible to include logical operators? For instance, 
one could filter for “PC 32:1 AND PE 32:1”, or “38:5 OR 38:6”.
○
--> A paragraph was added in the Display options section: “The search box allows the user to 
search for one or two queries using the logical operators AND / OR. Selecting the AND 
operator, the user can view lipid subclasses or molecular species for which the name 
implies both queries. For example, searching for “PC” and “34:0” on the lipid molecular 
species graph displays lipids “PC(34:0)” and “O-PC(34:0)”. Choosing the OR operator allow 
the user to visualise lipids whose names includes one of the two searches. For instance, 
searching “LPC” or “LPA” on the subclasses graph displays lipids “LPC”, “O-LPC” and “LPA”.”.
Ultimately, the tool relies on information contained in the pathway database. While using 
an in-house dataset for testing the tool, a large number of species were unfortunately 
“unprocessed”. Could the authors suggest how community users could help enriching the 
database?
○
--> A paragraph was added in the operation section to address the “unprocessed” molecular 
species within BioPAN: “The unprocessed category corresponds to lipid molecular species 
that did not have a matching molecular species, as a reactant and product, with the same 
number of carbons and double bonds. For example, a substrate molecular species, such as 
PA 34:2 should have a matching product with the same sum composition (e.g. DG 34:2).  
Additionally, some biological reactions require fatty acid or fatty-acyl-CoA molecular species. 
So, a lack of these subclasses in the input file prevents BioPAN to build up the reaction 
between substrates and products. If the substrate or product is not part of other reaction 
within the pathway, BioPAN will report it as unprocessed, such is the case of 
triacylglycerides (TG) subclasses. On other instances, like phosphatidylcholine (PC) and 
lysophosphatidylcholine (LPC), where PC is the substrate in the reaction to produce 
phosphatidic acid (PA) and LPC is the substrate to produce lysophosphatidic acid (LPA), 
those lipid subclasses molecular species can be considered as processed by BioPAN.”.
The export function is useful, but only allows for exports of .png and .jpg graphics, the 
resolution of which seems to depend on the zoom status in the display window. Would it be 
possible to add an option to export as vector graphics, .svg for example?
○
--> This capability of export graphics in SVG has been added and a sentence was included in 
the text “in several formats (JPEG / PNG / SGV / JSON / TXT)”. 
 
Minor comments 
1.         Page 1, Abstract, line 3: change “increase” to “increases”. 
Done, thank you 
 
2.         Page 2, Authors roles, line 1: change “visualization” to “visualisation”. 
Done, thank you 
  
3.         Page 5, right column, 3rdparagraph, line 3-4: change “visualized” to “visualised”. 
Done, thank you 
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4.         Page 9, Acknowledgements: change “In memorium” to “In memoriam”. 
Done, thank you  
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